Abiraterone acetate improves functional status in patients with metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel - Results from the COU-AA-301 phase 3 study Meeting Abstract
| Authors: | Harland, S.; de Bono, J. S.; Haqq, C. M.; Staffurth, J. N.; Hao, Y.; Gagnon, D.; Liu, C.; Sternberg, C. N.; Molina, A.; Scher, H. I. |
| Abstract Title: | Abiraterone acetate improves functional status in patients with metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel - Results from the COU-AA-301 phase 3 study |
| Meeting Title: | 16th ECCO - 36th ESMO - 30th ESTRO European Multidisciplinary Cancer Congress (EMCC 2011) |
| Journal Title: | European Journal of Cancer |
| Volume: | 47 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2011 Sep 23-27 |
| Meeting Location: | Stockholm, Sweden |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2011-09-01 |
| Start Page: | S484 |
| Language: | English |
| ACCESSION: | WOS:000295752801678 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(11)71952-9 |
| Notes: | --- - Meeting Abstract: 7001 - European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care - SEP 23-27, 2011 - Stockholm, SWEDEN - "Source: Wos" |
